Technical Analysis for GNBT - Generex Biotechnology Corporatio

Grade Last Price % Change Price Change
grade F 2.18 -0.91% -0.0200
GNBT closed down 0.91 percent on Tuesday, August 20, 2019, on 1.22 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical GNBT trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion -0.91%
Hammer Candlestick Bullish 6.34%
Calm After Storm Range Contraction 6.34%
Wide Bands Range Expansion 6.34%
Lower Bollinger Band Touch Weakness 6.34%
New Downtrend Bearish 6.34%
Calm After Storm Range Contraction 6.34%
Narrow Range Bar Range Contraction 6.34%

Older signals for GNBT ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist device. Antigen Express, Inc. is a wholly owned subsidiary of Generex. The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases. Antigen Express has pioneered the use of specific CD4+ T-helper stimulation technologies in immunotherapy. One focuses on modification of peptides with Ii-Key to increase potency, while a second relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T-helper cells and prevents the further growth of cancer cells. For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.
Medicine Medical Specialties Branches Of Biology Cancer Immune System Immunotherapy Autoimmune Diseases Drug Delivery Platform Technology Drug Delivery Systems Platform Technologies Antigen T Cell
Is GNBT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 25.3
52 Week Low 0.65
Average Volume 114,828
200-Day Moving Average 3.4313
50-Day Moving Average 2.4618
20-Day Moving Average 2.4598
10-Day Moving Average 2.236
Average True Range 0.2816
ADX 28.03
+DI 17.1027
-DI 30.5006
Chandelier Exit (Long, 3 ATRs ) 2.3552
Chandelier Exit (Short, 3 ATRs ) 2.4448
Upper Bollinger Band 3.0297
Lower Bollinger Band 1.8899
Percent B (%b) 0.25
BandWidth 46.337101
MACD Line -0.1205
MACD Signal Line -0.0674
MACD Histogram -0.0531
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.4650
Resistance 3 (R3) 2.4867 2.4133 2.4175
Resistance 2 (R2) 2.4133 2.3408 2.4025 2.4017
Resistance 1 (R1) 2.2967 2.2959 2.3550 2.2750 2.3858
Pivot Point 2.2233 2.2233 2.2525 2.2125 2.2233
Support 1 (S1) 2.1067 2.1508 2.1650 2.0850 1.9742
Support 2 (S2) 2.0333 2.1059 2.0225 1.9583
Support 3 (S3) 1.9167 2.0333 1.9425
Support 4 (S4) 1.8950